Mizuho Securities Co. Ltd. Invitae Corp Transaction History

Mizuho Securities Co. Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$2.13 - $9.01 $2 - $9	-1 Reduced 0.59%	169 $3,000
Q4 2021 Feb 04, 2022	BUY	$14.7 - $28.67 $14 - $28	1 Added 0.59%	170 $3,000
Q3 2021 Nov 05, 2021	BUY	$24.31 - $33.6 $121 - $168	5 Added 3.05%	169 $5,000
Q2 2021 Aug 05, 2021	BUY	$26.09 - $40.4 $4,278 - $6,625	164 New	164 $6,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $37,700 - $55,000	-2,000 Closed	0 $0

Q2 2019 Jul 31, 2019	BUY	$17.37 - $26.27 $34,740 - $52,540	2,000 New	2,000 $47,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.